Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cytek Biosciences (CTKB) Other Non Operating Income (2020 - 2025)

Cytek Biosciences' Other Non Operating Income history spans 6 years, with the latest figure at $258000.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income fell 47.45% year-over-year to $258000.0; the TTM value through Dec 2025 reached $8.8 million, up 97.18%, while the annual FY2025 figure was $8.8 million, 97.2% up from the prior year.
  • Other Non Operating Income reached $258000.0 in Q4 2025 per CTKB's latest filing, down from $1.3 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $3.7 million in Q2 2025 to a low of -$615000.0 in Q1 2021.
  • Average Other Non Operating Income over 5 years is $1.0 million, with a median of $657000.0 recorded in 2024.
  • Peak YoY movement for Other Non Operating Income: crashed 312.43% in 2021, then surged 6184.75% in 2025.
  • A 5-year view of Other Non Operating Income shows it stood at -$399000.0 in 2021, then surged by 624.06% to $2.1 million in 2022, then surged by 52.75% to $3.2 million in 2023, then tumbled by 84.63% to $491000.0 in 2024, then crashed by 47.45% to $258000.0 in 2025.
  • Per Business Quant, the three most recent readings for CTKB's Other Non Operating Income are $258000.0 (Q4 2025), $1.3 million (Q3 2025), and $3.7 million (Q2 2025).